Addiction - Articles - Page 6 | CARLAT PUBLISHING

CLINICAL UPDATE

Despair, Loneliness, and Substance Use Disorders

October 21, 2020

Rehan Aziz, MD. Associate Professor of Psychiatry and Neurology, Rutgers Robert Wood Johnson Medical School. Dr. Aziz has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Loneliness is a readily measurable phenomenon and it predicts worse outcomes in addiction treatment on the individual and population levels. What can we do in the clinic to combat loneliness and promote social cohesion?

EXPERT Q&A

Telemedicine for Addiction Treatment: Evidence and Implementation Strategies

August 6, 2020

Dallas Swendeman, PhD, MPH

Dallas Swendeman, PhD, MPH
Associate Professor, Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine at UCLA Dr. Swendeman has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

As many clinicians embark on new telemedicine efforts, we review the body of literature around virtual approaches to the care of patients with addiction. Dr. Swendeman reviews the evidence of efficacy for electronic self-monitoring, text-messaging, and other strategies may support your practice, and how to implement them.

EXPERT Q&A

Personal Privacy Versus Public Safety: Addiction Among Health Professionals

March 30, 2020

Paul H. Earley, MD, DFASAM

Paul H. Earley, MD, DFASAM
Medical director of the Georgia Professionals Health Program, Inc. Distinguished Fellow of ASAM. President of the Federation of State Physician Health Programs. Dr. Earley has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Dr. Paul Earley, president-elect of the Federation of Physician Health Programs, outlines the offerings of physician health programs, how to engage yourself or colleagues in treatment, and how treatment may interface with medical boards.

CLINICAL UPDATE

Primer: Physical Examination in Addiction Practice

November 22, 2019

Whether you are referring your patient for a physical or doing an initial one yourself, clinicians should be familiar with the basics of physical examination with a focus on knowing how to look for medical complications of addiction. This article walks you through a basic physical exam and what signs and symptoms to look for in patients with current or past substance use.

Screening and Prophylaxis of Infectious Diseases in Addiction Practice

November 22, 2019

Sandra Springer, MD

Sandra Springer, MD

Associate Professor of Medicine in the Department of Internal Medicine, Yale School of Medicine. Director of the Infectious Disease Clinic (Newington) and Attending Infectious Disease Physician (West Haven), VA Connecticut Healthcare System.

Dr. Springer has disclosed that she has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

In this QA, we invite Dr. Sandra Springer to walk us through the various screenings for infectious diseases ranging from HIV to Hepatitis A, Hepatitis B, and Hepatitis C, as well as Tuberculosis.

PrEP: Introduction to the Basics

November 22, 2019

With the rate of new HIV infections at just under 40,000 new infections per year, it is important for addiction practitioners to be on the front lines of HIV prevention. This article and corresponding table cover the pre-exposure prophylaxis (PrEP) with Truvada.

Perioperative Management of Patients on Buprenorphine Maintenance

November 22, 2019

Gregory Acampora, MD

Gregory Acampora, MD

Psychiatrist, Pain Management Center, Massachusetts General Hospital/Harvard Center for Addiction Medicine, Boston, MA. Assistant Professor, Harvard Medical School.

Dr. Acampora has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

For patients on buprenorphine maintenance facing surgery, it is crucial to balance the need to minimize pain while addressing the risk of relapse. In this interview, Dr. Gregory Acampora guides us through the specifics on perioperatively managing patients on varying doses of buprenorphine maintenance.

Exposure Therapy Efficacious for PTSD Co-Occurring With Alcohol Use Disorder

November 22, 2019

Brian Frankel, MD

Brian Frankel, MD Dr. Frankel has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Prolonged exposure is one of the best treatments available for patients with PTSD. This study examines the advantages of using prolonged exposure for patients who have PTSD with co-occurring alcohol use disorder.

Varenicline and Bupropion: Soaring Again With EAGLES?

November 22, 2019

Nicholas Rosenlicht, MD.

Nicholas Rosenlicht, MD. Dr. Rosenlicht has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

This research update unpacks the details behind the landmark “EAGLES” trial (Evaluating Adverse Events in a Global Smoking Cessation Study), which led to the removal of the varenicline black box warning.

The COMBINE Study: A Core Paper in the Treatment of AUD

November 22, 2019

Brian Frankel, MD

Brian Frankel, MD Dr. Frankel has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

This research update summarizes the results of the landmark COMBINE study which evaluated the effectiveness of stand-alone and combined pharmacological and behavioral interventions for treating alcohol use disorder.